Your SlideShare is downloading. ×
Renal cell carcinoma global clinical trials review, h1, 2014
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Renal cell carcinoma global clinical trials review, h1, 2014

41
views

Published on

GlobalData's clinical trial report, Renal Cell Carcinoma Global Clinical Trials Review, H1, 2014" provides data on the Renal Cell Carcinoma clinical trial scenario. This report provides elemental …

GlobalData's clinical trial report, Renal Cell Carcinoma Global Clinical Trials Review, H1, 2014" provides data on the Renal Cell Carcinoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Renal Cell Carcinoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Renal Cell Carcinoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Published in: Business, Health & Medicine

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
41
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
0
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Renal Cell Carcinoma Global Clinical Trials Review, H1, 2014 Renal Cell Carcinoma Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, Renal Cell Carcinoma Global Clinical Trials Review, H1, 2014" provides data on the Renal Cell Carcinoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Renal Cell Carcinoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Renal Cell Carcinoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type - Listings of discontinued trials (suspended, withdrawn and terminated) Reasons to buy - Understand the dynamics of a particular indication in a condensed manner - Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more - Obtain discontinued trial listing for trials across the globe - Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies Table Of Contents table Of Contents 2 list Of Tables 4 list Of Figures 5 introduction 6 renal Cell Carcinoma 6 report Guidance 6 clinical Trials By Region 7 clinical Trials And Average Enrollment By Country 8 top Five Countries Contributing To Clinical Trials In Asia-pacific 10 top Five Countries Contributing To Clinical Trials In Europe 11 top Countries Contributing To Clinical Trials In North America 12 top Five Countries Contributing To Clinical Trials In Middle East And Africa 13 top Five Countries Contributing To Clinical Trials In Central And South America 14 clinical Trials By G7 Countries: Proportion Of Renal Cell Carcinoma To Oncology Clinical Trials 15 clinical Trials By Phase In G7 Countries 16 clinical Trials In G7 Countries By Trial Status 17 clinical Trials By E7 Countries: Proportion Of Renal Cell Carcinoma To Oncology Clinical Trials 18 clinical Trials By Phase In E7 Countries 19 clinical Trials In E7 Countries By Trial Status 20 clinical Trials By Phase 21 in Progress Trials By Phase 22 clinical Trials By Trial Status 23 clinical Trials By End Point Status 24 unaccomplished Trials Of Renal Cell Carcinoma 25 subjects Recruited Over A Period Of Time 34 clinical Trials By Sponsor Type 35 prominent Sponsors 36 top Companies Participating In Renal Cell Carcinoma Therapeutics Clinical Trials 37 prominent Drugs 39 latest Clinical Trials News On Renal Cell Carcinoma 40 apr 16, 2014: Cleveland Biolabs Announces The Successful Completion Of A Phase 1 Study Of Cbl0102 40 apr 07, 2014: Curis And Debiopharm Report Preclinical Data For Debio 0932 At Aacr Annual Meeting 2014 40 dec 05, 2013: Immunicum Reports Positive Phase I/ii-data For The Therapeutic Cancer Vaccine Intuvax In The Treatment Of Kidney Cancer 41 nov 07, 2013: Celldex Therapeutics' Cdx-1127 Well Tolerated And Demonstrates Anti-tumor Activity In Phase 1 Dose-escalation Study 41 sep 26, 2013: Combinability Of Crlx101 And Avastin Established In Clinical Trial In Renal Cell Carcinoma 42 clinical Trial Profiles 44 Renal Cell Carcinoma Global Clinical Trials Review, H1, 2014
  • 2. clinical Trial Overview Of Top Companies 44 pfizer Inc. 44 clinical Trial Overview Of Pfizer Inc. 44 novartis Ag 50 clinical Trial Overview Of Novartis Ag 50 bayer Ag 54 clinical Trial Overview Of Bayer Ag 54 glaxosmithkline Plc 58 clinical Trial Overview Of Glaxosmithkline Plc 58 f. Hoffmann-la Roche Ltd. 61 clinical Trial Overview Of F. Hoffmann-la Roche Ltd. 61 bristol-myers Squibb Company 64 clinical Trial Overview Of Bristol-myers Squibb Company 64 astrazeneca Plc 66 clinical Trial Overview Of Astrazeneca Plc 66 amgen Inc. 67 clinical Trial Overview Of Amgen Inc. 67 eli Lilly And Company 68 clinical Trial Overview Of Eli Lilly And Company 68 aveo Pharmaceuticals, Inc. 69 clinical Trial Overview Of Aveo Pharmaceuticals, Inc. 69 clinical Trial Overview Of Top Institutes / Government 70 national Cancer Institute 70 clinical Trial Overview Of National Cancer Institute 70 the University Of Texas M. D. Anderson Cancer Center 81 clinical Trial Overview Of The University Of Texas M. D. Anderson Cancer Center 81 memorial Sloan Kettering Cancer Center 83 clinical Trial Overview Of Memorial Sloan Kettering Cancer Center 83 european Organization For Research And Treatment Of Cancer 85 clinical Trial Overview Of European Organization For Research And Treatment Of Cancer 85 ucla's Jonsson Comprehensive Cancer Center 86 clinical Trial Overview Of Ucla's Jonsson Comprehensive Cancer Center 86 roswell Park Cancer Institute 87 clinical Trial Overview Of Roswell Park Cancer Institute 87 case Comprehensive Cancer Center 88 clinical Trial Overview Of Case Comprehensive Cancer Center 88 radboud University 89 clinical Trial Overview Of Radboud University 89 the University Of Chicago 90 clinical Trial Overview Of The University Of Chicago 90 beth Israel Deaconess Medical Center 91 clinical Trial Overview Of Beth Israel Deaconess Medical Center 91 five Key Clinical Profiles 92 appendix 212 abbreviations 212 definitions 212 research Methodology 213 secondary Research 213 about Globaldata 214 contact Us 214 disclaimer 214 source 215 ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price. Contact: M/s Sheela, 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-997-4948 Email: sales@researchmoz.us Website: http://www.researchmoz.us/ Renal Cell Carcinoma Global Clinical Trials Review, H1, 2014
  • 3. Renal Cell Carcinoma Global Clinical Trials Review, H1, 2014